Connecting brain science & business

Novo Nordisk foundation and novo seeds call for Applications & Objectives. The Exploratory pre-seed program is a stimulus fund established to accelerate commercialization of biomedical research findings and development of novel technologies and diagnostics in the life science area. Thus the program seeks to support application-oriented research and stimulate entrepreneurship by funding projects at a very early (pre-seed) stage.

An exploratory pre-seed grant is given to explore the potential and sustainability of the research finding and idea and to prepare the project for a full pre-seed grant at a later stage. The goal of the exploratory pre-seed grants is to test new ideas that may lead to development of new medical treatments, disease prevention and diagnosis methods as well as new biotechnology. 

The evaluation of the Exploratory pre-seed grant applications includes:
Stage of the research finding/idea and potential for commercialization
Significance and originality of the research finding/idea
The proposed approach and availability of the needed resources
The project milestones 
The applicant's qualifications

Eligibility

Faculty, researchers and students based at Scandinavian universities, hospitals and other knowledge institutions. Projects from incubator and greenhouse development programs are also eligible.

Awards

Grants can support activities costing from DKK 100,000 to DKK 500,000 during a grant period of 4-12 months. Exploratory pre-seed grants may fund research and personnel, as well as commercialization-related costs. Funding is not available for conferences and travel expenses.

Application procedure

Application form and guidelines can be found on the Novo Nordisk Foundation's website from 18 November 2011. Proposals must be submitted electronically via the Foundation's web portal.

Application deadline:

Full proposals must be submitted by 16:00 on 19 December 2011.

Notification
Applicants will be notified of the Exploratory pre-seed committee's decision in early April 2012

| More...